Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial
Authors:
Abstract
Objective To compare the safety and efficacy of quinine given by the rectal route with quinine given by the intramuscular route in children with moderately severe Plasmodium falciparum malaria. Design Randomised, open, clinical trial. Setting Health centre in Burkina Faso. Participants 898 children with moderately severe P falciparum malaria who were unable to take oral treatment. Intervention Rectal quinine (20 mg/kg diluted to 30 mg/ml in water solution) or intramuscular quinine (12.5 mg/kg) every 12 hours until oral quinine could be taken. Main outcome measures Primary safety outcome was the presence of blood in stools and secondary safety outcome was diarrhoea. Primary efficacy outcome was early treatment failure and secondary efficacy outcomes were late clinical and parasitological failures, fever clearance time, and time to oral intake. Results Blood in stools and diarrhoea were more common in children given quinine by the rectal route than by the intramuscular route (blood in stools: 5% v 1%, absolute difference 3.9%, 95% confidence interval 1.8% to 6.1%; diarrhoea: 5% v 1%, 3.5%, 1.3% to 5.7%). On anoscopy, inflammatory lesions (9/248, 3%) were associated with bloody striations in stools. Side effects of rectal quinine were rare and transitory. Local pain (90%), inflammation (79%), and transient impairment of mobility (15%) were observed with intramuscular quinine. Early treatment failure was higher in the rectal group (6% v 3%, absolute difference 3.0%, 95% confidence interval 0.2% to 5.9%). All except two children in each group had negative blood slide results at day 5. Fever recurrence at day 7 was higher in the intramuscular group (37/375 v 18/395, absolute difference 5.3%, 1.6% to 8.9%). Other efficacy outcomes (late clinical failure, late parasitological failure, fever clearance time, time to starting oral intake and rate of deterioration to severe malaria) did not differ. Conclusion Quinine given by the rectal route has an acceptable safety profile and could be used in the early management of moderately severe malaria in children in sub-Saharan Africa, halting progression to severe disease.Keywords
This publication has 21 references indexed in Scilit:
- Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trialThe Lancet, 2005
- Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trialBMJ, 2005
- Dose-Dependent Resorption of Quinine after Intrarectal Administration to Children with Moderate Plasmodium falciparum MalariaAntimicrobial Agents and Chemotherapy, 2004
- Comparative in vitro–in vivo study of two quinine rectal gel formulationsInternational Journal of Pharmaceutics, 2004
- Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised studyThe Lancet, 2004
- [Clinical and parasitological aspects of severe malaria in adults in an urban area of Bobo-Dioulasso (Burkina Faso)].2003
- [Traditional enema for newborns and infants in Bobo Dioulasso: health practice or socialisation].2003
- Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malariaBritish Journal of Clinical Pharmacology, 1996
- Intrarectal Quinimax® (an association of Cinchona alkaloids) for the treatment of Plasmodium falciparum malaria in children in Niger: efficacy and pharmacokineticsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Pharmacokinetics of Rectal Drug Administration, Part IClinical Pharmacokinetics, 1991